Prohost Letter #446
A Reevaluation of Prohost Biotech’s Picked Firms
We have already pinpointed some of the devastating and life-threatening diseases that have yet to find treatment. Prohost’s plans are about discovering small &/or large biotech or biopharma firms that demonstrate scientific capability for treating or curing these diseases.
Most of the firms that we picked for investment in yesteryears had solid scientific and managerial fundamentals. Many of them accomplished a lot and, hence, grew much larger, while other successful firms in the Prohost Portfolio were acquired by deep . . .
This content is for paid subscribers.
Prohost Letters August 9, 2021